Exponent, Inc. delivered a strong finish to 2025, with total revenues increasing 7.8% to $147.4 million in the fourth quarter of 2025 compared to the same period in 2024. Net income rose to $24.8 million, or $0.49 per diluted share, reflecting robust demand for its specialized expertise across various sectors.

Exponent's first quarter results exceeded expectations, with total revenues and revenues before reimbursements remaining approximately flat compared to the prior year. Net income and EBITDA decreased, while the company maintained its full-year guidance despite facing headwinds in the second quarter.

Exponent, Inc. reported a robust fourth quarter and fiscal year 2024, with total revenues increasing by 11.3% to $136.8 million in Q4 and 4.1% to $558.5 million for the full year. Net income also saw significant growth, reaching $23.6 million in Q4 and $109.0 million for the fiscal year, driven by strong demand across various industries and improved operational efficiency.

Exponent reported a 2% increase in total revenues to $136.3 million for Q3 2024. Net income rose to $26.0 million, or $0.50 per diluted share. The company's EBITDA margin expanded by 100 basis points.

Exponent reported flat total revenues, a 2% increase in revenues before reimbursements, and a 14% increase in net income for Q2 2024. Growth was driven by demand across the transportation, utilities, and medical device sectors, while facing headwinds in the consumer electronics and chemicals sectors.

Exponent's first quarter results for 2024 showed revenue growth with revenues before reimbursements increasing by 6.6% to $137.2 million. Net income increased to $30.1 million, or $0.59 per diluted share.

Exponent's Q4 2023 total revenues decreased by 3.5% to $122.9 million compared to Q4 2022. Revenues before reimbursements increased slightly by 1.1% to $113.9 million. Net income decreased to $20.9 million, or $0.41 per diluted share. The company faces headwinds in the consumer electronics sector and macroeconomic uncertainty impacting litigation and proactive work.

Exponent, Inc. reported a 5% increase in total revenues and a 9% increase in revenues before reimbursements for the third quarter of 2023. Net income increased slightly to $24.5 million, or $0.48 per diluted share.

Exponent's Q2 2023 showed a 9.7% increase in revenues before reimbursements, reaching $129.7 million, and earnings per diluted share increased to $0.50. Growth was driven by demand for reactive offerings and increased demand in the chemicals and life sciences sectors.

Exponent reported a solid start to the year with a 9.2% increase in total revenues and a 9% increase in revenues before reimbursements. The company's growth was supported by increased demand for reactive services and proactive engagements across various sectors. Exponent continues to invest in its team, increasing headcount by 12% year-over-year.

Exponent reported a 12.2% increase in total revenues and a 7.9% increase in revenues before reimbursements for Q4 2022. Net income increased to $22.5 million, or $0.44 per diluted share. The company saw broad-based strength across its diversified portfolio of services.

Exponent reported a 9.3% increase in total revenues to $127.2 million and a 6.2% increase in revenues before reimbursements to $115.1 million for the third quarter of 2022. Net income decreased slightly to $24.4 million, or $0.47 per diluted share. The company's business model demonstrated resilience, driven by strong demand for services and proactive engagements in consumer products and transportation.

Exponent's second quarter results showed an increase in total revenues and revenues before reimbursements. Net income also increased, and the company saw growth across several industries, including consumer products, chemicals, automotive, and life sciences.

Exponent, Inc. reported a 10.3% increase in total revenues to $128.5 million and a 7.6% increase in revenues before reimbursements to $117.9 million for the first quarter of 2022. Net income decreased to $29.6 million, or $0.56 per diluted share.

Exponent's fourth quarter results showed a 9.9% increase in total revenues to $113.5 million and a 7.2% increase in revenues before reimbursements to $104.3 million compared to the fourth quarter of 2020. Net income decreased to $20.4 million, or $0.38 per diluted share. The company's engineering and other scientific segment represented 81% of net revenues, while the environmental and health segment represented 19%.

Exponent, Inc. reported an 18% increase in total revenues to $116.4 million for the third quarter of 2021, with net income increasing to $24.6 million, or $0.46 per diluted share. The company's EBITDA margin expanded more than 350 basis points from the prior year period.

Exponent reported a strong second quarter with a 28% increase in net revenue and an expanded EBITDA margin of 630 basis points. The company's revenues from reactive engagements returned to pre-COVID-19 levels, and proactive projects grew significantly.

Exponent reported a slight decrease in total revenues for Q3 2020, with a 3% decrease to $98.7 million. However, the company expanded EBITDA margin by 60 basis points. Net income decreased to $18.1 million, or $0.34 per diluted share.

Exponent, Inc. reported a 12% decrease in net revenues for the second quarter of 2020, while maintaining a strong financial position with $190 million in cash, cash equivalents, and short-term investments and no debt. The company's interdisciplinary solutions remain in demand, particularly in areas related to safety, health, sustainability, and reliability.

Exponent reported a strong first quarter with a 7% increase in total revenues, reaching $106 million. Net income increased to $26.3 million, or $0.49 per diluted share. The company ended the quarter with $152 million in cash, cash equivalents, and short-term investments and no debt.

Exponent's Q4 2019 revenues increased by 20% to $110.1 million, with net income rising to $19.1 million, or $0.36 per diluted share. The company benefited from increased demand for energy storage and battery technology services, integrity management assessments, and international arbitration engagements.